To functionally link ARG1/AGMAT expression to arginine accumulation, Mossmann et al. used adeno-associated viral (AAV) vectors to artificially drive ARG1/AGMAT expression in liver tumours; doing so decreased tumour arginine levels and reduced tumour burden. The gene discussed is AGMAT; the disease is neoplasm.